Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5285777
Max Phase: Preclinical
Molecular Formula: C40H38N10O9
Molecular Weight: 802.81
Associated Items:
ID: ALA5285777
Max Phase: Preclinical
Molecular Formula: C40H38N10O9
Molecular Weight: 802.81
Associated Items:
Canonical SMILES: O=C(CCCO/N=C1C(=C2/C(=O)N(Cc3cn(CCOCCNc4cccc5c4C(=O)C(N4CCC(=O)NC4=O)C5=O)nn3)c3ccccc32)/Nc2ccccc2/1)NO
Standard InChI: InChI=1S/C40H38N10O9/c51-30-14-16-49(40(56)43-30)36-37(53)26-9-5-11-28(32(26)38(36)54)41-15-19-58-20-17-48-21-23(44-47-48)22-50-29-12-4-2-8-25(29)33(39(50)55)35-34(24-7-1-3-10-27(24)42-35)46-59-18-6-13-31(52)45-57/h1-5,7-12,21,36,41-42,57H,6,13-20,22H2,(H,45,52)(H,43,51,56)/b35-33-,46-34+
Standard InChI Key: FRNCOCWYGZQOLM-LUZNAUSMSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 802.81 | Molecular Weight (Monoisotopic): 802.2823 | AlogP: 2.49 | #Rotatable Bonds: 15 |
Polar Surface Area: 238.78 | Molecular Species: NEUTRAL | HBA: 15 | HBD: 5 |
#RO5 Violations: 2 | HBA (Lipinski): 19 | HBD (Lipinski): 5 | #RO5 Violations (Lipinski): 2 |
CX Acidic pKa: 8.89 | CX Basic pKa: 3.89 | CX LogP: 1.01 | CX LogD: 0.99 |
Aromatic Rings: 4 | Heavy Atoms: 59 | QED Weighted: 0.04 | Np Likeness Score: -0.72 |
1. Sun D, Zhang J, Dong G, He S, Sheng C.. (2022) Blocking Non-enzymatic Functions by PROTAC-Mediated Targeted Protein Degradation., 65 (21.0): [PMID:36306471] [10.1021/acs.jmedchem.2c01159] |
Source(1):